help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moll, R.
Right arrow Articles by Franke, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moll, R.
Right arrow Articles by Franke, W. W.

American Journal of Pathology, Vol 132, 123-144, Copyright © 1988 by American Society for Investigative Pathology


REGULAR ARTICLES

Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines

R Moll, T Achtstatter, E Becht, J Balcarova-Stander, M Ittensohn and WW Franke
Department of Pathology, University of Mainz Medical School, Federal Republic of Germany.

The pattern of cytokeratins expressed in normal urothelium has been compared with that of various forms of transitional cell carcinomas (TCCs; 21 cases) and cultured bladder carcinoma cell lines, using immunolocalization and gel electrophoretic techniques. In normal urothelium, all simple-epithelium-type cytokeratins (polypeptides 7, 8, 18, 19) were detected in all cell layers, whereas antibodies to cytokeratins typical for stratified epithelia reacted with certain basal cells only or, in the case of cytokeratin 13, with cells of the basal and intermediate layers. This pattern was essentially maintained in low-grade (G1, G1/2) TCCs but was remarkably modified in G2 TCCs. In G3 TCCs simple-epithelial cytokeratins were predominant whereas the amounts of component 13 were greatly reduced. Squamous metaplasia was accompanied generally by increased or new expression of some stratified- epithelial cytokeratins. The cytokeratin patterns of cell culture lines RT-112 and RT-4 resembled those of G1 and G2 TCCs, whereas cell line T- 24 was comparable to G3 carcinomas. The cell line EJ showed a markedly different pattern. The results indicate that, in the cell layers of the urothelium, the synthesis of stratification-related cytokeratins such as component 13 is inversely oriented compared with that in other stratified epithelia where these proteins are suprabasally expressed, that TCCs retain certain intrinsic cytoskeletal features of urothelium, and that different TCCs can be distinguished by their cytokeratin patterns. The potential value of these observations in histopathologic and cytologic diagnoses is discussed.


This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
J. Madoz-Gurpide, M. Canamero, L. Sanchez, J. Solano, P. Alfonso, and J. I. Casal
A Proteomics Analysis of Cell Signaling Alterations in Colorectal Cancer
Mol. Cell. Proteomics, December 1, 2007; 6(12): 2150 - 2164.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. D. Klein, C. S. Van Pelt, A. L. Sabichi, J. dela Cerda, S. M. Fischer, G. Furstenberger, and K. Muller-Decker
Transitional Cell Hyperplasia and Carcinomas in Urinary Bladders of Transgenic Mice with Keratin 5 Promoter-Driven Cyclooxygenase-2 Overexpression
Cancer Res., March 1, 2005; 65(5): 1808 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J. A. Ramos-Vara, M. A. Miller, M. Boucher, A. Roudabush, and G. C. Johnson
Immunohistochemical Detection of Uroplakin III, Cytokeratin 7, and Cytokeratin 20 in Canine Urothelial Tumors
Vet. Pathol., January 1, 2003; 40(1): 55 - 62.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. E. Celis, P. Celis, H. Palsdottir, M. Ostergaard, P. Gromov, H. Primdahl, T. F. Orntoft, H. Wolf, A. Celis, and I. Gromova
Proteomic Strategies to Reveal Tumor Heterogeneity among Urothelial Papillomas
Mol. Cell. Proteomics, April 1, 2002; 1(4): 269 - 279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Morifuji, S.’i. Taniguchi, H. Sakai, Y. Nakabeppu, and M. Ohishi
Differential Expression of Cytokeratin after Orthotopic Implantation of Newly Established Human Tongue Cancer Cell Lines of Defined Metastatic Ability
Am. J. Pathol., April 1, 2000; 156(4): 1317 - 1326.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. D. Lobban, B. A. Smith, G. D. Hall, P. Harnden, P. Roberts, P. J. Selby, L. K. Trejdosiewicz, and J. Southgate
Uroplakin Gene Expression by Normal and Neoplastic Human Urothelium
Am. J. Pathol., December 1, 1998; 153(6): 1957 - 1967.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Ehler, P. S. Jat, M. D. Noble, S. Citi, and A. Draeger
Vascular Smooth Muscle Cells of H-2Kb-tsA58 Transgenic Mice : Characterization of Cell Lines With Distinct Properties
Circulation, December 1, 1995; 92(11): 3289 - 3296.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Eto, S. S. Yoon, B. P. Bode, S. Kamidono, K. Makino, H. Saya, H. Nakamura, and K. K. Tanabe
Mapping and Regulation of the Tumor-associated Epitope Recognized by Monoclonal Antibody RS-11
J. Biol. Chem., August 25, 2000; 275(35): 27075 - 27083.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Society for Investigative Pathology.